Andrew Gomperts
Oprichter bij Hillhurst Biopharmaceuticals, Inc.
Oorsprong van het eerstegraads netwerk van Andrew Gomperts
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Hillhurst Biopharmaceuticals, Inc.
 Hillhurst Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Hillhurst Biopharmaceuticals, Inc. is a private company that specializes in developing a gas in liquid advanced stability system called Hillhurst's proprietary GLASSTM platform. The company is based in San Diego, CA. This platform enables novel uses of therapeutic gases that were previously limited by inhaled delivery. The company has developed a unique pipeline of novel liquid therapeutic candidates intended to treat patients with sickle cell disease, Parkinson's disease, and acute pain. The company was founded by Edward Gomperts. The CEO is Andrew Gomperts.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Andrew Gomperts via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|
Statistieken
Internationaal
Sectoraal
Operationeel
| Chairman | 1 |
| Founder | 1 |
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Edward Gomperts | 1 |
| Douglas Stockdale | 1 |
| Jeff Friedman | 1 |
- Beurs
- Insiders
- Andrew Gomperts
- Bedrijfsconnecties
